ImExHS Valuation Multiples

Discover revenue and EBITDA valuation multiples for ImExHS and similar public comparables like Welby, Physitrack, Metacare, MedApp and more.

ImExHS Overview

About ImExHS

ImExHS Ltd is engaged in the development and sale of its Hiruko software platform. The software consists of Radiology, Cardiology, Pathology information systems, and Picture Archiving and Communications Systems. The segments of the company are Software and Radiology Services. The company derives maximum revenue from Radiology segment.


Founded

2001

HQ

Australia

Employees

400

Website

imexhs.com

Financials (LTM)

Revenue: $20M
EBITDA: $1M

EV

$11M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

ImExHS Financials

ImExHS reported last 12-month revenue of $20M and EBITDA of $1M.

In the same LTM period, ImExHS generated $1M in EBITDA and had net loss of ($2M).

Revenue (LTM)


ImExHS P&L

In the most recent fiscal year, ImExHS reported revenue of $20M and EBITDA of $1M.

ImExHS is unprofitable as of last fiscal year, with gross margin of 99%, EBITDA margin of 6%, and net margin of (10%).

See analyst estimates for ImExHS
LTMLast FY202320242025202620272028
Revenue$20M$20M$14M$18M$20M
Gross Profit-$20M$14M$18M$20M
Gross Margin-99%100%100%100%
EBITDA$1M$1M($875K)$32K($314K)
EBITDA Margin6%6%(6%)0%(2%)
EBIT Margin(2%)(2%)(13%)(8%)(3%)
Net Profit($2M)($2M)($3M)($2M)($2M)
Net Margin(10%)(10%)(21%)(10%)(10%)

Financial data powered by Morningstar, Inc.

ImExHS Stock Performance

ImExHS has current market cap of $13M, and enterprise value of $11M.

Market Cap Evolution


ImExHS's stock price is $0.24.

ImExHS share price decreased by 0.7% in the last 30 days, and increased by 15.6% in the last year.

ImExHS has an EPS (earnings per share) of $-0.04.

See more trading valuation data for ImExHS
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$11M$13M0.0%-0.7%-12.2%15.6%$-0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

ImExHS Valuation Multiples

ImExHS trades at 0.5x EV/Revenue multiple, and 9.6x EV/EBITDA.

See NTM and 2027E valuation multiples for ImExHS

EV / Revenue (LTM)


ImExHS Financial Valuation Multiples

As of July 6, 2026, ImExHS has market cap of $13M and EV of $11M.

ImExHS has a P/E ratio of (6.3x).

LTMLast FY202320242025202620272028
EV/Revenue0.5x0.5x0.8x0.6x0.6x
EV/EBITDA9.6x9.6x(12.7x)n/m(35.4x)
EV/EBIT(26.4x)(26.4x)(6.2x)(7.2x)(17.9x)
EV/Gross Profit-0.6x0.8x0.6x0.6x
P/E(6.3x)(6.5x)(4.5x)(7.1x)(6.5x)
EV/FCF26.0x26.0x38.7x(5.8x)(23.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified ImExHS Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

ImExHS Margins & Growth Rates

In the most recent fiscal year, ImExHS reported gross margin of 99%, EBITDA margin of 6%, and net margin of (10%).

See estimated margins and future growth rates for ImExHS

ImExHS Margins

Last FY20242025202720282029
Gross Margin99%100%100%
EBITDA Margin6%0%(2%)
EBIT Margin(2%)(8%)(3%)
Net Margin(10%)(10%)(10%)
FCF Margin2%(11%)(2%)

ImExHS Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth34%10%
Gross Profit Growth34%10%
EBITDA Growth(104%)(1093%)
EBIT Growth(14%)(60%)
Net Profit Growth(37%)10%
FCF Growth(772%)(76%)

Data powered by FactSet, Inc. and Morningstar, Inc.

ImExHS Operational KPIs

ImExHS's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for ImExHS
Last FY202320242025202620272028
Revenue per Employee$0.1M---
Opex per Employee$0.1M---
S&M Expenses to Revenue1%1%0%1%
G&A Expenses to Revenue28%28%28%29%
R&D Expenses to Revenue8%8%7%8%
Opex to Revenue102%113%108%103%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

ImExHS Competitors

ImExHS competitors include Welby, Physitrack, Metacare, MedApp, Resonance Health, Vidavo, NRGene, Media Lab, AMA Corp and MRSO.

Most ImExHS public comparables operate across Healthcare Software, HealthTech, B2B SaaS and Vertical SaaS.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Welby3.2x3.2x(4.2x)-
Physitrack1.1x1.1x(8.0x)11.5x
Metacare2.2x-12.8x-
MedApp14.0x-(168.4x)-
Resonance Health2.0x-(24.4x)-
Vidavo3.9x-10.2x-
NRGene1.4x-(4.5x)-
Media Lab5.2x-23.0x-

This data is available for Pro users. Sign up to see all ImExHS competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About ImExHS

When was ImExHS founded?ImExHS was founded in 2001.
Where is ImExHS headquartered?ImExHS is headquartered in Australia.
How many employees does ImExHS have?As of today, ImExHS has over 400 employees.
Is ImExHS publicly listed?Yes, ImExHS is a public company listed on Australian Securities Exchange.
What is the stock symbol of ImExHS?ImExHS trades under IME ticker.
When did ImExHS go public?ImExHS went public in 2005.
Who are competitors of ImExHS?ImExHS main competitors include Welby, Physitrack, Metacare, MedApp, Resonance Health, Vidavo, NRGene, Media Lab, AMA Corp, MRSO.
What is the current market cap of ImExHS?ImExHS's current market cap is $13M.
What is the current revenue of ImExHS?ImExHS's last 12 months revenue is $20M.
What is the current EV/Revenue multiple of ImExHS?Current revenue multiple of ImExHS is 0.5x.
What is the current EBITDA of ImExHS?ImExHS's last 12 months EBITDA is $1M.
What is ImExHS's EBITDA margin?ImExHS's last 12 months EBITDA margin is 6%.
What is the current EV/EBITDA multiple of ImExHS?Current EBITDA multiple of ImExHS is 9.6x.
What is the current FCF of ImExHS?ImExHS's last 12 months FCF is $428K.
What is ImExHS's FCF margin?ImExHS's last 12 months FCF margin is 2%.
What is the current EV/FCF multiple of ImExHS?Current FCF multiple of ImExHS is 26.0x.
How many companies ImExHS has acquired to date?ImExHS hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies ImExHS has invested to date?ImExHS hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to ImExHS

Lists including ImExHS

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial